Return to homepagePandemic Pact

Understanding the adaptive evolution of pathogens to predict and so prevent or reduce drug resistance: A proof of concept study for dynamic residue network analysis with applications to SARS-CoV-2 Mpro

Grant search

Key facts

  • Disease

    COVID-19, Disease X

  • start year

    2023

  • Known Financial Commitments (USD)

    $438.61

  • Funder

    Novo Nordisk Foundation

  • Principal Investigator

    .

  • Research Location

    South Africa

  • Lead Research Institution

    Rhodes University

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract